Мифы и легенды гастроэнтерологии. Гастрит не болит и другие разоблачения

^4. Lembo A. et al. AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea. Gastroenterology 2022; 163(1):137–151.

^5. Vasant D. et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021; 70(7):1214–1240.

^6. Drossman D. et al. Rome Foundation clinical diagnostic criteria for disorders of gutbrain interaction. Gastroenterology 2022; 162(3):675–679.

^7. Cash B. et al. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97(11):2812–2819.

^8. Gralnek I. et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119(3):654–660.

^9. Клинические рекомендации Министерства здравоохранения Российской Федерации «Синдром раздраженного кишечника», 2021 год. Доступны на сайте https://cr.minzdrav.gov.ru/

^10. National Institute for Health and Care Excellence (NICE). Irritable bowel syndrome in adults. 3rd ed. London: National Institute for Health and Care Excellence (NICE); 2017.

^11. Bayer S. et al. Habitual green kiwifruit consumption is associated with a reduction in upper gastrointestinal symptoms: a systematic scoping review. Adv Nutr 2022; 13(3):846–856.

^12. Chey W. et al. AGA clinical practice update on the role of diet in irritable bowel syndrome: expert review. Gastroenterology 2022; 162(6):1737–1745.

К главе 7

^1. Singh P. et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018; 16(6):823–836.

^2. Tortora R. et al. Coeliac disease in the elderly in a tertiary centre. Scand J Gastroenterol 2016; 51:1179–1183.

^3.

Cappello M. et al. Elderly onset celiac disease: a narrative review. Clin Med Insights Gastroenterol 2016;9:41–49.

^4. Bai J. World Gastroenterology Organisation global guidelines: celiac disease. J Clin Gastroenterol 2017; 51(9):755–768.

^5. Туе-Din J. et al. Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective. Intern Med J 2015; 45(4):441–450.

^6. Cohen I. et al. Gluten in celiac disease-more or less? Rambam Maimonides Med J 2019; 10(l):e0007.

^7. Akobeng A. et al. Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Then 2008; 27(ll):1044–1052.

^8. Food and Drug Administration Health hazard assessment for gluten exposure in Individuals with celiac disease: determination of tolerable daily intake levels and levels of concern for gluten. Электронная ссылка http://bit.ly/2QCT6TH.

^9.

Thompson T. et al. Gluten contamination of grains, seeds, and flours in the United States: a pilot study. J Am Diet Assoc 2010; 110(6):937–940.

^10. Koerner T. etal. Gluten contamination in the Canadian commercial oat supply. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2011; 28(6):705–710.

^11. Dale H. et al. Assessment of markers of gut integrity and inflammation in non-celiac gluten sensitivity after a gluten free-diet. Int J Gen Med 2021; 14:9459–9470.

^12. Ajamian M. et al. Effect of gluten ingestion and F0DMAP restriction on intestinal epithelial integrity in patients with irritable bowel syndrome and self-reported non-coeliac gluten sensitivity. Mol Nutr Food Res 2021; 65(5):el901275.

^13. Monteiro M. et al. Autism spectrum disorder: a systematic review about nutritional interventions. Rev Paul Pediatr 2020; 38:e2018262.

^14. Lionetti E. et al. Re-challenge studies in non-celiac gluten sensitivity: a systematic review and meta-analysis. Front Physiol 2017; 8:621.

^15. Potter M. et al. Incidence and prevalence of self-reported non-coeliac wheat sensitivity and gluten avoidance in Australia. Med J Aust 2020; 212(3): 126–131.

^16.

Diez-Sampedro A. et aL A gluten-free diet, not an appropriate choice without a medical diagnosis. J Nutr Metab 2019; 2019:2438934.

К главе 8

^1. De Vos W. et al. Gut microbiome and health: mechanistic insights. Gut 2022; 71(5): 1020–1032.

^2. Jandhyala S. et al. Role of the normal gut microbiota. World J Gastroenterol 2015; 21(29):8787–803.

^3. Leviatan S. et al. An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species. Nat Commun 2022; 13(1):3863.

^4. Ивашкин B. T. и соавт. Практические рекомендации Научного сообщества по содействию клиническому изучению микробиома человека (НС0ИМ) и Российской гастроэнтерологической ассоциации (РГА) по диагностике и лечению синдрома избыточного бактериального роста у взрослых. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022; 32(3):68–85.

^5. Pimentel М. et al. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol 2020;115(2):165–178.

К главе 9

^1. Dale H. et al. Assessment of markers of gut integrity and inflammation in non-celiac gluten sensitivity after a gluten free-diet. Int J Gen Med 2021; 14:9459–9470.